INHIBITOR OF ACTIVITY OF CHOLESTEROL ESTERIFIED TRANSPORT PROTEIN, PROPHYLACTIC OR THERAPEUTIC AGENT, DERIVATIVES OF BIS-(2-AMIDOPHENYL)-DISULFIDE OR AMIDOTHIOPHENOL Russian patent published in 2002 - IPC

Abstract RU 2188631 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to an inhibitor of activity of cholesterol esterified transport protein comprising as an active component the compound presented by the formula (I) where R means direct or branched alkyl group; lower halogenalkyl group; substituted or unsubstituted cycloalkyl group; substituted or unsubstituted cycloalkylalkyl group; substituted or unsubstituted aryl group, or substituted or unsubstituted heterocyclic group; X1, X2, X3, X4 can be similar or different and each means hydrogen atom, halogen atom, lower alkyl group, lower halogenalkyl group; lower alkoxy-group; cyano-group; nitro-group; Y means CO- and Z means hydrogen atom or mercapto-protecting group, or its pharmaceutically acceptable salt or hydrate, or solvate. Compounds presented by the formula (I) can increase the level of high density lipoproteins (HDL) and in the same time decrease the level of low density lipoproteins (LDL) by selective inhibition of activity of cholesterol esterified transport protein and therefore as suggested they can be used as prophylactic or therapeutic agents of new type for treatment of atherosclerosis or hyperlipidemia. EFFECT: new compounds indicated above, valuable medicinal properties. 24 cl, 48 tbl

Similar patents RU2188631C2

Title Year Author Number
CETP-INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITIONS 2004
  • Sunami Masaki
  • Serigano Takanori
RU2318504C2
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION 2004
  • Okamoto Khirosi
  • Furukava Noboru
  • Sasase Tomokhiko
RU2330682C2
THERAPEUTIC AGENT FOR TREATMENT OF DIABETIC PATIENTS 1997
  • Sinkai Khisasi
  • Ozeki Khidekazu
  • Furukava Noboru
RU2174114C2
METHOD OF SYNTHESIS OF OXAZOLE COMPOUND 1999
  • Matsuda Kodzi
  • Khara Katsuesi
  • Akamatsu Minoru
RU2194042C1
SOLID COMPOSITION WITH IMPROVED SOLUBILITY AND STABILITY AND METHOD OF OBTAINING IT 2005
  • Jamane Sogo
  • Jamane Khirofumi
  • Sunami Masaki
RU2375046C2
METHOD OF SYNTHESIS OF ISOXAZOLIDINEDIONE COMPOUND, METHOD OF SYNTHESIS OF OXAZOLYLETHANOL COMPOUND (VARIANTS), METHOD OF SYNTHESIS OF ASPARTATE COMPOUND, METHOD OF SYNTHESIS OF OXAZOLYLACETATE COMPOUND, METHOD OF SYNTHESIS OF METHANESULFONATE COMPOUND, METHOD OF SYNTHESIS OF BENZYLIDENE COMPOUND 1999
  • Ando Kodzi
  • Suzuki Masanobu
RU2180663C2
PYRAZOLE COMPOUND AND ITS PHARMACEUTICAL USE 2012
  • Miura Tomoya
  • Ogosi Esuke
  • Ueyama Kadzukhito
  • Motoda Daj
  • Ivayama Tosikhiko
  • Sudzava Kojti
  • Nagamori Khironobu
  • Ueno Khirosi
  • Takakhasi Akikhiko
  • Sugimoto Kadzuyuki
RU2617678C2
AMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION ELICITING INHIBITORY EFFECT ON XA FACTOR 1999
  • Katokh Susumu
  • Ekota Katsujuki
  • Khajasi Mikio
RU2201927C2
DERIVATIVES OF PHENYLAMIDINE 1996
  • Anderskevitts Ral'F
  • Shromm Kurt
  • Rent Ehrnst-Otto
  • Birke Frants
  • Jennevajn Khans
  • Mid Kristofer
  • Ding Andreas
RU2184726C2
DIARYL COMPOUNDS WITH BRIDGE BOND 2002
  • Abe Khirojuki
  • Khauze Dzhonatan
  • Kavasaki Khisasi
  • Kajzer Frank
  • Sharma Radzhiv
  • Sperri Sam'Juehl
RU2297409C2

RU 2 188 631 C2

Authors

Sinkai Khisasi

Maeda Kimija

Okamoto Khirosi

Dates

2002-09-10Published

1998-02-10Filed